USPHNYSEServices-Health ServicesFiscal year ends December 31
U S PHYSICAL THERAPY INC /NV
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$83.91−1.80 (-2.10%)
Close on Oct 19, 2026
- Market cap
- $1.26B
- P/E (TTM)
- 59.1
- Dividend yield
- 2.15%
Share price
−$5.02 (−5.64%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
U S PHYSICAL THERAPY INC /NV grew revenue 11.3% to $812.20M over the twelve months to Jun 30, 2026. Operating income fell 0.7% to $76.52M, moving the operating margin from 10.6% to 9.4%. Free cash flow was $64.07M, up 5.3% from a year earlier.
Revenue
$812.20M
+11.3% vs. a year earlier
Operating income
$76.52M
-0.7% vs. a year earlier
Free cash flow
$64.07M
+5.3% vs. a year earlier
EPS, diluted
$1.42
-22.8% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.26B
- P/E ratio
- 59.1
- Price to sales
- 1.56
- Price to book
- 2.82
- Dividend yield
- 2.15%
- Free cash flow yield
- 5.07%
Fundamentals
- Revenue
- $812.20M
- Net income
- $32.23M
- EPS, diluted
- $1.42
- Free cash flow
- $64.07M
- Book value per share
- $29.77
- Diluted shares
- 15M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$812.20M+11.3% YoY
Gross profit
$151.70M+12.9% YoY
Operating income
$76.52M-0.7% YoY
Net income
$32.23M-15.6% YoY
EPS, diluted
–
Free cash flow
$64.07M+5.3% YoY
Reported periodTrailing twelve months